Drug Registration and Acceptance

Drug Name

Exact

Active Ingredient

Acceptance No.

Manufacturers

Acceptance Date

Status Date

Classification

Review Status

Drug Type

Submission

Evaluation Conclusion

ATC Category

Special Approval Varieties

Task Type

Major Special Varieties

Sequence No.

Stock Code

Visualized Analysis Export Evaluation Conclusion Evaluation Progress

Acceptance No.	Drug Name	Active Ingredient	Dosage Form	Classification	Submission	Acceptance Date	Manufacturers	Manufacturers	Review Status	Status Date	View
JYHB2001341	吸入用布地奈德混悬液	budesonide	Suspension	Chemical Drugs	Supplementary Application	2020-08-21	AstraZeneca Pty Ltd	Astrazeneca Pty Ltd	Filed	2020-09-09	view
JYHB2001342	吸入用布地奈德混悬液	budesonide	Suspension	Chemical Drugs	Supplementary Application	2020-08-21	AstraZeneca Pty Ltd	Astrazeneca Pty Ltd	Filed	2020-09-09	view
JYHB1900537	吸入用布地奈德混悬液	budesonide	Suspension	Chemical Drugs	Supplementary Application	2019-05-15	AstraZeneca Pty Ltd	Astrazeneca Pty Ltd	Certificate Issued	2020-01-10	view
JYHB1900536	吸入用布地奈德混悬液	budesonide	Suspension	Chemical Drugs	Supplementary Application	2019-05-15	AstraZeneca Pty Ltd	Astrazeneca Pty Ltd	Certificate Issued	2020-01-10	view
JYHZ1800416	吸入用布地奈德混悬液	budesonide	Suspension	Chemical Drugs	License Renew	2018-12-14	AstraZeneca Pty Ltd	Astrazeneca Pty Ltd	Certificate Issued	2019-06-11	view
JYHZ1800415	吸入用布地奈德混悬液	budesonide	Suspension	Chemical Drugs	License Renew	2018-12-14	AstraZeneca Pty Ltd	Astrazeneca Pty Ltd	Certificate Issued	2019-06-11	view
JYHB1800659	吸入用布地奈德混悬液	budesonide	Suspension	Chemical Drugs	Supplementary Application	2018-06-07	AstraZeneca Pty Ltd	Astrazeneca Pty Ltd	Filed	2018-06-22	view
JYHB1800660	吸入用布地奈德混悬液	budesonide	Suspension	Chemical Drugs	Supplementary Application	2018-06-07	AstraZeneca Pty Ltd	Astrazeneca Pty Ltd	Filed	2018-06-22	view
JYHB1502028	吸入用布地奈德混悬液	budesonide	Suspension	Chemical Drugs	Supplementary Application	2015-12-11	AstraZeneca Pty Ltd	Astrazeneca Pty Ltd	Certificate Issued	2018-11-26	view
JYHB1502025	吸入用布地奈德混悬液	budesonide	Suspension	Chemical Drugs	Supplementary Application	2015-12-11	AstraZeneca Pty Ltd	Astrazeneca Pty Ltd	Certificate Issued	2018-11-26	view
JYHZ1400605	盐酸罗哌卡因注射液	ropivacaine hydrochloride	Injection	Chemical Drugs	License Renew	2015-03-01	AstraZeneca Pty Ltd	Astrazeneca Pty Ltd	Certificate Issued	2018-03-02	view
JYHB1300328	吸入用布地奈德混悬液	budesonide	Suspension	Chemical Drugs	Supplementary Application	2013-03-07	AstraZeneca Pty Ltd	Astrazeneca Pty Ltd	Certificate Issued	2015-10-30	view
JYHB1300327	吸入用布地奈德混悬液	budesonide	Suspension	Chemical Drugs	Supplementary Application	2013-03-07	AstraZeneca Pty Ltd	Astrazeneca Pty Ltd	Certificate Issued	2015-10-30	view
JYHB1000686	吸入用布地奈德混悬液	budesonide	Suspension	Chemical Drugs	Supplementary Application	2010-09-15	AstraZeneca Pty Ltd	Astrazeneca Pty Ltd	Certificate Issued	2011-01-24	view
JYHB1000685	吸入用布地奈德混悬液	budesonide	Suspension	Chemical Drugs	Supplementary Application	2010-09-15	AstraZeneca Pty Ltd	Astrazeneca Pty Ltd	Certificate Issued	2011-01-24	view
JYHZ0800375	吸入用布地奈德混悬液	budesonide	Suspension	Chemical Drugs	License Renew	2008-08-27	AstraZeneca Pty Ltd	Astrazeneca Pty Ltd	Certificate Issued	2009-11-02	view
JYHZ0800376	吸入用布地奈德混悬液	budesonide	Suspension	Chemical Drugs	License Renew	2008-08-22	AstraZeneca Pty Ltd	Astrazeneca Pty Ltd	Certificate Issued	2009-11-02	view
JYHB0600136	吉非替尼片	gefitinib	Tablet	Chemical Drugs	Supplementary Application	2006-03-10	AstraZeneca Pty Ltd	Astrazeneca Pty Ltd	Certificate Issued	2006-09-22	view
JYHB0500150	吉非替尼片	gefitinib	Tablet	Chemical Drugs	Supplementary Application	2005-04-13	AstraZeneca Pty Ltd	Astrazeneca Pty Ltd	Filed	2005-10-12	view
J0301768	吉非替尼片	gefitinib	Tablet	Chemical Drugs	Supplementary Application	2003-12-28	AstraZeneca Pty Ltd	Astrazeneca Pty Ltd	Certificate Issued	2004-06-25	view